LENZ Therapeutics (LENZ) Non-Current Assets (2020 - 2026)

LENZ Therapeutics (LENZ) has 7 years of Non-Current Assets data on file, last reported at $4.2 million in Q1 2026.

• On a quarterly basis, Non-Current Assets rose 22.84% year-over-year to $4.2 million in Q1 2026; TTM through Mar 2026 was $16.1 million, a 20.17% increase from a year earlier, with the FY2025 full-year figure at $4.5 million, up 31.8% from the prior year.
• Non-Current Assets for Q1 2026 stood at $4.2 million, down from $4.5 million in the prior quarter.
• Over the last five years, Non-Current Assets for LENZ reached as high as $46.5 million in Q4 2022 and fell as low as $648000.0 in Q1 2024.
• Historically, Non-Current Assets has averaged $16.5 million across 5 years, with a median of $4.2 million in 2026.
• Across the five-year window, Non-Current Assets soared 1053.02% in 2022 and plunged 98.37% in 2024, its largest moves.
• Year by year, Non-Current Assets stood at $46.5 million in 2022, then plunged by 93.27% to $3.1 million in 2023, then climbed by 8.14% to $3.4 million in 2024, then soared by 31.8% to $4.5 million in 2025, then slipped by 6.63% to $4.2 million in 2026.
• Per Business Quant data, the three most recent Non-Current Assets figures were $4.2 million in Q1 2026, $4.5 million in Q4 2025, and $3.7 million in Q3 2025.